-
Mashup Score: 2Shawn Kwatra, MD, Reviews Late-Breaking Data of Abrocitinib for Prurigo Nodularis and Chronic Pruritus of Unknown Origin - 6 month(s) ago
Kwatra presented the abrocitinib data at EADV 2023.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Sleep Disorders Associated With Dermatologic Conditions - 11 month(s) ago
Certain skin conditions such as atopic dermatitis and psoriasis are associated with sleep disturbances and disorders.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Several dermatologic conditions are associated with sleep disturbances and disorders, including #AtopicDermatitis and #psoriasis, predominantly due to severe itch and #pruritus. https://t.co/fXLEpsUmk3
-
-
Mashup Score: 0Pruritus: Diagnosis and Management - 11 month(s) ago
Pruritus is the sensation of itching; it can be caused by dermatologic and systemic conditions. An exposure history may reveal symptom triggers. A thorough skin examination, including visualization of the finger webs, anogenital region, nails, and scalp, is essential. Primary skin lesions indicate diseased skin, and secondary lesions are reactive and result from skin manipulation, such as…
Source: www.aafp.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Top 20 Article of 2022—Pruritus: Diagnosis and Management https://t.co/imnQeq1RPc #familymedicine #Top20AFP2022 #pruritus https://t.co/dd64D6ADzb
-
-
Mashup Score: 1First Patient Dosed in Clinical Trial Combatting Pruritus - 11 month(s) ago
Topline results for the topical sodium channel blocker are expected in 2024.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
NEW: The first patient has been dosed in a clinical trial investigating the efficacy of ASN008-201, a topical sodium channel blocker, in reducing #pruritus associated with #AtopicDermatitis. https://t.co/byVunUqSCf
-
-
Mashup Score: 2Spontaneous resolution of intractable prurigo nodularis after subinsular cortex stroke - 1 year(s) ago
Prurigo nodularis (PN) is a chronic skin condition characterized by the formation of cutaneous nodules caused by repetitive scratching. Pathogenesis of PN implicates dysregulation of neuroimmunologic circuits that potentiate the itch-scratch cycle.1 Development of unilateral PN after contralateral strokes in various brain regions have been reported,2,3 suggesting a role of the central nervous…
Source: JAAD Case ReportsCategories: Dermatology, Latest HeadlinesTweet-
A 56-year-old man presented to the dermatology clinic with a >15 year history of severe #pruritus on the bilateral upper portion of the back and neck with >50 excoriated, hyperpigmented, hyperkeratotic and lichenified papules/nodules consistent with PN... https://t.co/AC3gH5ExQa
-
-
Mashup Score: 0
Growing evidence indicates that transient receptor potential (TRP) channels contribute to different forms of pruritus. However, the endogenous mediators that cause itch through transient receptor potential channels signaling are poorly understood. In this study, we show that genetic deletion or pharmacological antagonism of TRPV4 attenuated itch in a mouse model of psoriasis induced by topical…
Categories: Dermatology, Latest HeadlinesTweet-
De Logu et al reveal the unconventional pathophysiological role for TRPV4 in mediating #pruritus of #psoriasis and an extracellular microRNA: miR-203b-3p that can behave as an itch promoter through activation of 5-HTR2B and TRPV4. @UNI_FIRENZE #TRPV4 https://t.co/AABg09dDGR https://t.co/EtREWK7f9C
-
-
Mashup Score: 0
Linerixibat induced a dose-dependent reduction in itch among patients with primary biliary cholangitis-associated pruritus, according to results published in Clinical Gastroenterology and Hepatology. “Pruritus is commonly associated with primary biliary cholangitis, present in nearly 75% of patients over the disease course,” Cynthia Levy, MD, FAASLD, AGAF, of the University of Miami
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from @AGA_CGH: #Linerixibat may relieve #itch in #primarybiliarycholangitis-associated #pruritus #GITwitter #MedTwitter https://t.co/dXT4cBFefJ
-
-
Mashup Score: 0
Linerixibat induced a dose-dependent reduction in itch among patients with primary biliary cholangitis-associated pruritus, according to results published in Clinical Gastroenterology and Hepatology. “Pruritus is commonly associated with primary biliary cholangitis, present in nearly 75% of patients over the disease course,” Cynthia Levy, MD, FAASLD, AGAF, of the University of Miami
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Linerixibat induced a dose-dependent reduction in #itch among patients with #primarybiliarycholangitis-associated #pruritus, according to results published in @AGA_CGH #GITwitter #Medtwitter https://t.co/dXT4cBFefJ
-
-
Mashup Score: 0
A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
A real-world study of children with moderate-to-severe #atopicdermatitis (AD) in China found #Dupixent can reduce symptoms and improve #pruritus. Traditional therapies had little effect, according to the researchers. https://t.co/mqDiwF2Snd
-
-
Mashup Score: 1Study Examines Association Between Undifferentiated Pruritus and Hematologic Cancers - 2 year(s) ago
The careful consideration of cancer risk is especially important during the first year after the presentation of pruritus.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers set out to assess the risk of #hematologicCancer in patients with undifferentiated #pruritus and developed a retrospective cohort study to analyze medical records of 327,502 patients and 327,502 control subjects. Published in @JAMADerm. https://t.co/0MX4JVfcCi
-
New: @drshawnkwatra , discusses new late-breaking data on the safety and efficacy of #abrocitinib for the treatment #PrurigoNodularis and chronic #pruritus of unknown origin presented at EADV 2023. https://t.co/9MEEdTpzWf